Short- and long-term effects of IL-1 and TNF antagonists on periodontal wound healing

Journal of Immunology

Volumn 173, Issue 5, 2004, Pages 3514-3523

  Zhang, Xuemei ^a   Kohli, Malika ^a   Zhou, Qingde ^a   Graves, Dana T ^a   Amar, Salomon ^a,b  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; INFLAMMATORY CELL; MALE; NONHUMAN; OSTEOCLAST; PERIODONTAL DISEASE; PRIMATE; PRIORITY JOURNAL; WOUND HEALING;

EID: 4344655341     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.5.3514     Document Type: Article

References (62)

1. Martin, P. 1997. Wound healing: aiming for perfect skin regeneration. Science 276:75.
2. Clark, R. 1995. Wound repair: overview and general considerations. In The Molecular and Cellular Biology of Wound Repair. R. Clark, ed. Plenum Press, New York, p. 1.
3. Wikesjo, U. M., and K. A. Selvig. 1999. Periodontal wound healing and regeneration. Periodontol. 2000 19:21.
4. Karring, T., S. Nyman, J. Gottlow, and L. Laurell. 1993. Development of the biological concept of guided tissue regeneration: animal and human studies. Periodontol. 2000 1:26.
5. Werfully, S., G. Areibi, M. Toner, J. Bergquist, J. Walker, S. Renvert, and N. Claffey. 2002. Tensile strength, histological and immunohistochemical observations of periodontal wound healing in the dog. J. Periodontal Res. 37:366.
6. Leibovich, S. J., P. J. Polverini, H. M. Shepard, D. M. Wiseman, V. Shively, and N. Nuseir. 1987. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 329:630.
7. March, C. J., B. Mosley, A. Larsen, D. P. Cerretti, G. Braedt, V. Price, S. Gillis, C. S. Henney, S. R. Kronheim, K. Grabstein, et al. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641.
8. Beutler, B., and A. Cerami. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320:584.
9. Nathan, C. 2002. Points of control in inflammation. Nature 420:846.
10. Graves, D. T., A. J. Delima, R. Assuma, S. Amar, T. Oates, and D. Cochran. 1998. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J. Periodontol. 69:1419.
11. Meghji, S., W. Qureshi, B. Henderson, and M. Harris. 1996. The role of endotoxin and cytokines in the pathologenesis of odontogenic cysts. Arch. Oral Biol. 41:523.
12. Dinarello, C. A. 1996. Biologic basis of interleukin-1 in disease. Blood 87:2095.
13. Wustrow, T. P. 1994. Biology of interleukin-1 (IL-1) with respect to otorhinolaryngology: head and neck surgery. Head Neck 16:88.
14. Fortunato, S. J., and R. Menon. 2003. IL-1β is a better inducer of apoptosis in human fetal membranes than IL-6. Placenta 24:922.
15. Awane, M., P. G. Andres, D. J. Li, and H. C. Reieaker. 1999. NF-κB-induced kinase is a common mediatior of IL-17, TNF-α, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162:5337.
16. Dinarello, C. A. 1993. Modalities for reducing interleukin-1 Immunol. Today 14:260.
17. Graves, D. T., N. Nooh, T. Gillen, M. Davey, S. Patel, D. Cottrell, and S. Amar. 2001. IL-1 plays a critical role in oral, but not dermal, wound healing. J. Immunol. 167:5316.
18. Angele, M. K., M. W. Knoferl, A. Ayala, J. E. Albina, W. G. Cioffi, K. I. Bland, and I. H. Chaudry. 1999. Trauma-Hemorrhage delays wound healing potentially by increasing proinflammatory cytokines at the wound site. Surgery 126:279.
19. Trengove, N. J., H. Bielefeldt-Ohmann, and M. C. Stacey. 2000. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen. 8:13.
20. Colotta, F., S. K. Dower, J. E. Sims, and A. Mantovani. 1994. The type II "decoy" receptor: a novel regulatory pathway for interleukin-1. Immunol. Today 15:562.
21. Giri, J. G., R. C. Newton, and R. Horuk. 1990. Identifications of soluble interleukin-1 binding protein in cell-free supernatants. J. Biol. Chem. 265:17416.
22. Dinarello, C. A., and S. M. Wolff. 1993. The role of IL-1 in diseases. N. Engl. J. Med. 328:106.
23. Delima, A. J., S. Karatzas, S. Amar, and D. T. Graves. 2002. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J. Infect. Dis. 186:511.
24. Rosenbaum, J. T., and R. S. Boney. 1991. Use of a soluble interleukin-1 receptor to inhibit ocular inflammation. Curr. Eye Res. 10:1137.
25. Tehranian, R., S. Andell-Jonsson, S. M. Beni, I. Yatsiv, E. Shohami, T. Bartfai, J. Lundkvist, and K. Iverfeldt. 2002. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 19:939.
26. Kohno, T., M. T. Brewer, S. L. Baker, P. E. Schwartz, M. W. King, K. K. Hale, C. H. Squires, R. C. Thompson, and J. L. Vannice. 1990. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87:8331.
27. Declercq, W., G. Denecker, W. Fiers, and P. Vandenabeele. 1998. Cooperation of both TNF receptors in inducing apoptosis: involovement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J. Immunol. 161:390.
28. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-βB in preventing TNF-α induced cell death. Science 274:782.
29. Graves, D. T. 1999. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin. Infect. Dis. 28:482.
30. Feldmann, M., F. M. Brennan, M. J. Elliot, R. O. Williams, and R. N. Maini. 1995. TNFα is a therapeutic target for rheumatoid arthritis. Ann. NY Acad. Sci. 766:272.
31. Raine, C. S. 1995. Multiple sclerosis: TNF revisited, with promise. Nat. Med. 1:211.
32. Rapala, K. 1996. The effect of tumor necrosis factor-α on wound healing: an experimental study. Ann. Chir. Gynaecol. Suppl. 211:1.
33. Mallett, S., and A. N. Barclay. 1991. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 12:220.
34. Mori, R., T. Kondo, T. Ohshima, Y. Ishida, and N. Mukaida. 2002. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16:963.
35. Zhang, M. H., and K. J. Tracey. 1998. Tumor necrosis factor. In The Cytokine Handbook. A. W. Thomson, ed. Academic Press, San Diego, p. 517.
36. Kremer, J. M., M. E. Weinblatt, A. D. Bankhurst, K. J. Bulpitt, R. M. Fleischmann, C. G. Jackson, K. M. Atkins, A. Feng, and D. J. Burge. 2003. Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Arthritis Rheum. 48:1493.
37. Gorman, J. D., K. E. Sack, and J. C. Davis, Jr. 2002. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N. Engl. J. Med. 346:1349.
38. Leonardi, C. L., J. L. Powers, R. T. Matheson, B. S. Goffe, R. Zitnik, A. Wang, A. B. Gottlieb, and Etanercept Psoriasis Study Group. 2003. Etanercept as monotherapy in patients with psoriasis. N. Engl. J. Med. 349:2014.
39. Assuma, R., T. Oates, D. Cochran, S. Amar, and D. T. Graves. 1998. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 160:403.
40. Caton, J., L. Mota, L. Gandini, and B. Laskaris. 1994. Non-human primate models for testing efficacy and safety of periodontal regeneration procedures. J. Periodontol. 65:1143.
41. Amar, S., K. M. Chung, S. H. Nam, S. Karatzas, F. Myokai, and T. E. Van Dyke. 1997. Markers of bone and cementum formation accumulate in tissues regenerated in peirodontal defects treated with expanded polytetrafluoroethylene membranes. J. Periodontal Res. 32:148.
42. Karatzas, S., A. Zavras, D. Greenspan, and S. Amar. 1999. Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. Int. J. Periodontics Restorative Dent. 19:489.
43. Chiang, C. Y., G. Kyritsis, D. T. Graves, and S. Amar. 1999. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect. Immun. 67:4231.
44. Gavrieli. Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
45. Kosaka, H., N. Harada, M. Watanabe, H. Yoshihara, Y. Katsuki, and T. Shiga. 1992. Synergistic stimulation of nitric oxide hemoglobin production in rats by recombinant interleukin 1 and tumor necrosis factor. Biochem. Biophys. Res. Commun. 189:392.
46. Kumar, A., V. Thota, L. Dee, J. Olson, E. Uretz, and J. E. Parrillo. 1996. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J. Exp. Med. 183:949.
47. Caldwell, J., and S. G. Emerson. 1995. Interleukin-1α upregulates tumor necrosis factor receptors expressed by a human bone marrow stromal cell strain: implications for cytokine redundancy and synergy. Blood 86:3364.
48. Delima, A. J., T. Oates, R. Assuma, Z. Schwartz, D. Cochran, S. Amar, and D. T. Graves. 2001. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibit loss of tissue attachment in experimental periodontitis. J. Clin. Periodontol. 28:233.
49. Kim, S. H., E. R. Lechman, S. Kim, J. Nash, T. J. Oligino, and P. D. Robbins. 2002. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. Mol. Ther. 6:591.
50. Ulich, T. R., E. S. Yi, S. Yin, C. Smith, and D. Remick. 1994. Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation. Clin. Immunol. Immunopathol. 72:137.
51. Kagari, T., T. Doi, and T. Shimozato. 2002. The importance of IL-1β and TNF-α and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169:1459.
52. Kadokami, T., C. Frye, B. Lemster, C. L. Wagner, A. M. Feldman, and C. F. McTiernan. 2001. Anti-tumor necrosis factor-α antibody limits heart failure in a transgenic model. Circulation 104:1094.
53. Nahar, I. K., K. Shojania, C. A. Marra, A. H. Alamgir, and A. H. Anis. 2003. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann. Pharmacother. 37:1256.
54. Scripter, J. L., J. Ko, K. Kow, A. Arimura, and C. F. Ide. 1997. Regulation by interleukin-1β of formation of a line of delimiting atrocytes following prenatal trauma to the brain of the mouse. Exp. Neurol. 145:329.
55. Graves, D. T., and D. Cochran. 2003. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J. Periodontol. 74:391.
56. Tracey, K. J. 2002. The inflammatory reflex. Nature 420:853.
57. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093.
58. Kanaly, S. T., M. Nashleanas, B. Hondowicz, and P. Scott. 1999. TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens. J. Immunol. 163:3883.
59. Dayer-Metroz, M. D., D. Duhamel, and N. Rufer. 1992. IL-1Ra delays the spontaneous autoimmune diabetes in the BB rat. Eur. J. Clin. Invest. 22:A50.
60. Barrier, B. F., G. W. Bates, M. M. Leland, D. A. Leach, R. D. Robinson, and A. M. Propst. 2004. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil. Steril. 81:775.
61. Kudo, O., Y. Fujikawa, I. Itonaga, A. Sabokbar, T. Torisu, and N. A. Athanasou. 2002. Proinflammatory cytokine (TNFα/IL-1α) induction of human osteoclast formation. J. Pathol. 198:220.
62. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. 2000. Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275.